Metis Neutraceuticals Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2016.
2016 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Metis Neutraceuticals Private Limited

Metis Neutraceuticals Private Limited, a struck off private limited company, was established on 08 March 2016 in New Delhi, Delhi, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100DL2016PTC292307. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Bharat Gulia (Director), Gaurav Gulia (Director), Sumit Sharma (Additional Director). It is based at 2090, Sector-D, Vasant Kunj,, New Delhi, Delhi, 110070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100DL2016PTC292307

  • Registration Number

    292307

  • Incorporation Date

    08 March 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 3 Days
Company report

Metis Neutraceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Metis Neutraceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Metis Neutraceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Bharat Gulia Director 08 Mar 2016 Current
Gaurav Gulia Director 08 Mar 2016 Current
Sumit Sharma Additional Director 22 Jun 2016 Current
Sundeep Verma Additional Director 30 Sep 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Metis Neutraceuticals.

Enhance accessibility to Metis Neutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Metis Neutraceuticals revenue growth over time
Metis Neutraceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Metis Neutraceuticals?

Unlock access to Metis Neutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Metis Neutraceuticals?

Unlock and access historical data on people associated with Metis Neutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Metis Neutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metis Neutraceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Metis Neutraceuticals
Recent Activity within the Organization
  • Director Appointment

    Sundeep Verma was appointed as a Additional Director was appointed as a Additional Director on 30 Sep 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sumit Sharma was appointed as a Additional Director was appointed as a Additional Director on 22 Jun 2016 & has been associated with this company since 9 years 8 months . was documented.

  • Director Appointment

    Progress on Bharat Gulia was appointed as a Director was appointed as a Director on 08 Mar 2016 & has been associated with this company since 10 years 3 days . was documented.

  • Director Appointment

    Progress on Gaurav Gulia was appointed as a Director was appointed as a Director on 08 Mar 2016 & has been associated with this company since 10 years 3 days . was documented.

  • Company Incorporation

    Progress on Metis Neutraceuticals Private Limited was registered on 08 Mar 2016 with Roc Delhi & aged 10 years 3 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Metis Neutraceuticals Private Limited?

The CIN of Metis Neutraceuticals Private Limited is U85100DL2016PTC292307.

Where is Metis Neutraceuticals Private Limited headquartered?

Metis Neutraceuticals Private Limited is headquartered at 2090, Sector-D, Vasant Kunj,, New Delhi, Delhi, 110070.

When was Metis Neutraceuticals Private Limited incorporated?

Metis Neutraceuticals Private Limited was incorporated on 08 March 2016.

Who are the current directors of Metis Neutraceuticals Private Limited?

The current directors of Metis Neutraceuticals Private Limited are

What is the primary industry of Metis Neutraceuticals Private Limited?

The primary industry of Metis Neutraceuticals Private Limited is Healthcare.

Is Metis Neutraceuticals Private Limited a listed company?

Metis Neutraceuticals Private Limited is unlisted.

What is the capital structure of Metis Neutraceuticals Private Limited?

The authorized capital of Metis Neutraceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Metis Neutraceuticals Private Limited?

The compliance status of Metis Neutraceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available